Inflammation Research

, Volume 44, Issue 2, pp 70–73 | Cite as

Bradykinin-induced vasodilation is changed to a vasoconstrictor response in vessels of aged normotensive and hypertensive rats

  • Laura Mantelli
  • Sandra Amerini
  • Fabrizio Ledda


The vascular response to bradykinin was investigated in mesenteric vascular bed preparations preconstricted with methoxamine, obtained from 2- and 18-month old normotensive (WKY) and spontaneously hypertensive (SHR) rats. In preparations from young normotensive rats bradykinin (1 nm-10 µM) produced an endothelium-dependent vasorelaxant effect which was greatly reduced by the B2 receptor antagonist Ac-D-Arg[Hyp3,D-Phe7,Leu8]-bradykinin (1 µM), and was unaffected by the B1 receptor antagonist des-Arg9,[Leu8]-bradykinin (1 µM). The degree of vasodilation was similar in preparations from age-matched SHR rats. In vessels obtained from old animals bradykinin induced an endothelium-independent vasoconstrictor response; this effect was more pronounced in preparations from SHR than in those from WKY rats. The vasoconstriction was unaffected by both B1 and B2 receptor antagonists, and was abolished by 3 µM indomethacin. We conclude that the vasorelaxant effect of bradykinin in vessels of young animals is due to stimulation of B2 receptors. This vasodilating response can be converted by aging to a vasoconstriction and is probably due to the release of a prostanoid product; moreover it is more pronounced in spontaneously hypertensive animals.

Key words

Bradykinin Spontaneously hypertensive rats (SHR) Mesenteric vascular bed Aging 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Haddy FJ, Emerson TE Jr, Scott JB, Daugherty RM Jr. The effects of kinins on the cardiovascular system. Handb Exptl Pharmacol 1970;25:362–84.Google Scholar
  2. [2]
    Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980;32:1–46.Google Scholar
  3. [3]
    Toda N. Actions of bradykinin on isolated cerebral and peripheral arteries. Am J Physiol 1977;232:H267-H274.Google Scholar
  4. [4]
    Förstermann U, Hertting G, Neufang B. The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin. Br J Pharmacol 1986;87:521–32.Google Scholar
  5. [5]
    Ohde H, Morimoto HS, Ohnishi K, Yamaoka E, Fukuo K, Yasuda O, Ogihara T. Bradykinin suppresses endothelininduced contraction of coronary, renal and femoral arteries through its B2-receptor on the endothelium. Agents and Actions 1992;38/III:14–22.Google Scholar
  6. [6]
    Nagao T, Vanhoutte PM. Characterization of endotheliumdependent relaxations resistant to nitro-L-arginine in the porcine coronary artery. Br J Pharmacol 1992;107:1102–7.Google Scholar
  7. [7]
    Salgado MCO, Caldo H, Rodrigues MCG. Effect of bradykinin on isolated mesenteric arteries of the rat. Hypertension 2992;19 (suppl II):1II-251-4.Google Scholar
  8. [8]
    Yen MH, Lai CS. Mechanism of contractile responses to bradykinin in canine basilar arteries. Eur J Pharmacol 1992;221:261–6.Google Scholar
  9. [9]
    Calixto JB, Medeiros YS. Effect of protein kinase C and calcium on bradykinin-mediated contractions of rabbit vessels. Hypertension 1992;19 (suppl II):II-87-93.Google Scholar
  10. [10]
    Levesque L, Drapeau G, Grose JH, Rioux F, Marceau F. Vascular mode of action of kinin-B1 receptors and development of a cellular model for the investigation of these receptors. Br J Pharmacol 1993;109:1254–62.Google Scholar
  11. [11]
    Fasciolo JC, Vargas L, Lama MC, Nolly H. Bradykinininduced vasoconstriction of rat mesenteric arteries precontracted with noradrenaline. Br J Pharmacol 1990;101:344–8.Google Scholar
  12. [12]
    Criscione L, Mueller K, Prescott MF. Endothelial cell loss enhances the pressor response in resistance vessels. J Hypertension 1984;2 (suppl):441–4.Google Scholar
  13. [13]
    Berguer R, Hottenstein OD, Palen TE, Stewart JM, Jacobson ED. Bradykinin-induced mesenteric vasodilation is mediated by B2-subtype receptors and nitric oxide. Am J Physiol 1993;264 (3 Pt 1):G492-G496.Google Scholar
  14. [14]
    Santiago JA, Osei SY, Kadowitz PJ. Inhibitory effects of Hoe 140 on vasodilator responses to bradykinin in the mesenteric vascular bed of the cat. Br J Pharmacol 1993;236:315–18.Google Scholar
  15. [15]
    Baydoun AR, Woodward B. Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor. Br J Pharmacol 1991;103:1829–33.Google Scholar
  16. [16]
    Bouthillier J, Deblois D, Marceau F. Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo. Br J Pharmacol 1987;92:257–64.Google Scholar
  17. [17]
    Regoli D, Marceau F, Barabé J. De novo formation of vascular receptor for bradykinin. Can J Physiol Pharmacol 1978;56:674–7.Google Scholar
  18. [18]
    Regoli D, Marceau F, Lavigne J. Induction of theB 1-receptors for kinins in the rabbit by bacterial lipopolysaccharide. Eur J Pharmacol 1981;71:105–15.Google Scholar
  19. [19]
    Tropea MM, Gummelt D, Herzig MS, Leeb-Lundberg LMF. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by Des-Arg9-bradykinin and bradykinin. J Pharmacol Exp Ther 1993;264:930–7.Google Scholar
  20. [20]
    Briner VA, Tsai P, Schrier RW. Bradykinin: potential for vascular constriction in the presence of endothelial injury. Am J Physiol 1993;264:F322-F327.Google Scholar

Copyright information

© Birkhäuser Verlag 1995

Authors and Affiliations

  • Laura Mantelli
    • 1
  • Sandra Amerini
    • 1
  • Fabrizio Ledda
    • 1
  1. 1.Department of PharmacologyUniversity of FlorenceFirenzeItaly

Personalised recommendations